Add Company
Join Now

Complement Therapeutics Revenue and Competitors

License our Company Data API

London, London

Location

#2144

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Complement Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Complement Therapeutics's estimated revenue per employee is $77,500
  • Complement Therapeutics's total funding is $85M.

Employee Data

  • Complement Therapeutics has 32 Employees.(i)
  • Complement Therapeutics grew their employee count by 100% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M1623%N/AN/A
#2
$11.8M7621%N/AN/A
#3
$1.8M2335%N/AN/A
#4
$2.2M2961%N/AN/A
#5
$1.8M2335%N/AN/A
#6
$0.9M129%N/AN/A
#7
$0.1M10%N/AN/A
#8
$18.3M118-3%N/AN/A
#9
$0.5M620%N/AN/A
#10
$4.8M6241%N/AN/A
Add Company

What Is Complement Therapeutics?

Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for dry age-related macular degeneration/geographic atrophy, a leading cause of blindness. Additional programmes will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company is also developing a unique quantification methodology, the Complement Precision Medicine (CPM) platform, to enable quantification of over 30 complement cascade proteins enabling more precise diagnosis and monitoring of disease.

keywords:N/A

$85M

Total Funding

32

Number of Employees

$2.5M

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M32-11%N/A
#2
$6.2M320%N/A
#3
$3.3M320%N/A
#4
$4.2M327%N/A
#5
$6.4M323%N/A